Disease-specific signals

The term 'Disease-specific signals' refers to a broad conceptual category of biological indicators, molecular signatures, or pathological pathways that characterize a specific disease state. It is not a specific therapeutic target, receptor, or enzyme, but rather a descriptor for various biomarkers (such as cytokines, mutated proteins, or metabolic shifts) used to distinguish diseased tissue from healthy tissue (National Institutes of Health, 2023). Because it lacks a unique biochemical structure or a specific gene locus, it cannot be directly modulated by a single drug. Instead, these signals are used in research and diagnostics to identify specific actionable targets or to monitor disease progression and patient response to therapy (PubMed, 2022). In the context of drug discovery, a 'disease-specific signal' might refer to the aberrant activity of an entire signaling network, which requires the identification of specific protein components before a drug can be developed.

Other names

Disease-associated signalsPathological signaturesMolecular disease signalsClinical biomarkers

Not applicable. This is a broad conceptual term and not a discrete molecular entity or therapeutic target.